New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta butterfly symbolism…
November 27, 2025 09:30 ET | Source: GS1 Canada TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- A new report prepared…
November 26, 2025 16:05 ET | Source: PetMed Express, Inc. DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed…
BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on…
$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full…
November 25, 2025 18:15 ET | Source: Ascendis Pharma – Prescription Drug User Fee Act (PDUFA) goal date extended by…
KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available in the United…
The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift…
York, Pennsylvania, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Pennsylvania Perio & Implants today announced the reinforcement of its evidence-based framework…
SHANGHAI, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…